Overview of TEAEs (safety population)
Deaths
ADVERSE EVENT
TEAEs are defined as any adverse event that occurs after administration of the first dose of study treatment through 28 days after last dose of study treatment, or until the start of subsequent antineoplastic therapy. Deaths occurred within 28 days of last treatment dose. Percentages are based on the number of patients in each treatment group for the designated population of this table.